Aurora Cannabis (ACB) Current Assets (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Current Assets of $289.8 million for Q1 2026, down 13.06% year-over-year from $333.4 million in Q1 2025, and down 13.06% quarter-over-quarter from $333.4 million in Q1 2025.
Aurora Cannabis (ACB) Current Assets (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Current Assets for 9 consecutive years, with $289.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets fell 13.06% year-over-year to $289.8 million; the TTM figure through Mar 2026 stood at $289.8 million (down 13.06% YoY), while the FY2026 annual figure was $289.8 million, down 15.77% from the prior year.
- Current Assets retreated to $289.8 million in Q1 2026 per ACB's latest filing, from $333.4 million in the prior quarter.
- Across five years, Current Assets topped out at $584.4 million in Q2 2022 and bottomed at $289.8 million in Q1 2026.
- Historically, Current Assets has averaged $356.7 million across 5 years, with a median of $326.7 million in 2024.
- Annual changes were most pronounced in 2022 — Current Assets climbed 7.88% — and 2026, when it dropped 13.06%.
- Aurora Cannabis' Current Assets stood at $584.4 million in 2022, then tumbled by 39.26% to $355.0 million in 2023, then dropped by 1.49% to $349.7 million in 2024, then fell by 4.68% to $333.4 million in 2025, then decreased by 13.06% to $289.8 million in 2026.
- Business Quant data shows ACB's Current Assets at $289.8 million in Q1 2026, $333.4 million in Q1 2025, and $349.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 3.22 Bn |
| 10 | Aurora Cannabis | 232.22 Mn | 159.91 Mn | 25.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 289.82 Mn |
| Mar 31, 2025 | 333.35 Mn |
| Dec 31, 2024 | 349.73 Mn |
| Sep 30, 2024 | 305.00 Mn |
| Jun 30, 2024 | 320.05 Mn |
| Mar 31, 2024 | 316.59 Mn |
| Mar 31, 2023 | 355.00 Mn |
| Jun 30, 2022 | 584.43 Mn |
| Jun 30, 2021 | 541.72 Mn |
| Jun 30, 2020 | 301.11 Mn |
| Jun 30, 2019 | 493.72 Mn |
| Jun 30, 2018 | 170.30 Mn |